DDR Pathway Alteration, Tumor Mutation Burden, and Cisplatin Sensitivity in Small Cell Lung Cancer: Difference Detected by Whole Exome and Targeted Gene Sequencing

J Thorac Oncol. 2019 Dec;14(12):e276-e279. doi: 10.1016/j.jtho.2019.08.2509.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cisplatin
  • DNA Damage
  • Exome
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Lung Neoplasms / genetics*
  • Mutation
  • Platinum
  • Small Cell Lung Carcinoma*

Substances

  • Platinum
  • Cisplatin